Delphine Fradin
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Methylated circulating tumor DNA: technical challenges and clinical applications in non-small cell lung cancer patients-a narrative review.
Journal: Translational lung cancer research
Published: November 19, 2025
Unlocking the power of non-coding RNAs: toward real-time cancer monitoring in precision oncology.
Journal: Molecular cancer
Published: August 05, 2025
Soluble PD-L1 (sPD-L1) as a biomarker of durable response and survival in patients with advanced non-small cell lung cancer (NSCLC) treated with first-line immune checkpoint inhibitors (ICIs).
Journal: Cancer immunology, immunotherapy : CII
Published: January 27, 2025
Reappraisal of the fundamental mechanisms of the sHA14-1 molecule as a Bcl-2/Bcl-XL ligand in the context of anticancer therapy: A cell biological study.
Journal: Journal of biological methods
Published: August 12, 2024
Loss of miR-200c-3p promotes resistance to radiation therapy via the DNA repair pathway in prostate cancer.
Journal: Cell death & disease
Published: February 01, 2024
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy.
Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy.
Journal: Respiratory research
Published: October 11, 2023
Oncolytic viruses alter the biogenesis of tumor extracellular vesicles and influence their immunogenicity.
Journal: Molecular therapy. Oncology
Published: June 28, 2023
TP53 mutations correlate with the non-coding RNA content of small extracellular vesicles in melanoma.
Journal: Journal of extracellular biology
Published: March 23, 2023
DNA methylation dynamics during pregnancy.
Journal: Frontiers in cell and developmental biology
Published: March 13, 2023
Therapeutic strategies for non-small cell lung cancer: Experimental models and emerging biomarkers to monitor drug efficacies.
Journal: Pharmacology & therapeutics
Published: September 15, 2022
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells.
Journal: Cancer immunology, immunotherapy : CII
Published: September 12, 2022
Last Updated: 09/26/2026